CCMH
ALNY icon

Cornerstone Capital Management Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,954
Closed -$751K – 1380
2016
Q1 		$751K Sell
11,954
-4,422
-27% -$294K 0.01% 960
2015
Q4 		$1.54M Sell
16,376
-6,575
-29% -$610K 0.01% 799
2015
Q3 		$1.84M Buy
22,951
+20,668
+905% +$2.3M 0.02% 743
2015
Q2 		$274K Sell
2,283
-33,405
-94% -$3.99M ﹤0.01% 1137
2015
Q1 		$3.73M Buy
35,688
+24,150
+209% +$2.45M 0.03% 516
2014
Q4 		$1.12M Buy
+11,538
New +$1.07M 0.01% 862

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return